Skip to main content

Sitagliptin

NDC 60505-3644 · Apotex Corp.

Generic nameSitagliptin
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)SITAGLIPTIN PHOSPHATE
Strength50 mg/1
Pharmacologic classDipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
Marketing categoryANDA

Packages

60505-3644-3 — 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3644-3)

60505-3644-9 — 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3644-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-1036 — sitagliptin, 50090-3472 — sitagliptin, 50090-3527 — sitagliptin, 50090-4084 — sitagliptin, 50090-4086 — sitagliptin, 50090-4087 — sitagliptin, 50090-5502 — SITAGLIPTIN and METFORMIN HYDROCHLORIDE, 50090-5504 — sitagliptin and metformin hydrochloride, 50090-5616 — SITAGLIPTIN and METFORMIN HYDROCHLORIDE, 55154-5040 — sitagliptin, 55154-5042 — sitagliptin, 60505-3643 — Sitagliptin, 60505-3645 — Sitagliptin, 60505-3658 — Sitagliptin and Metformin Hydrochloride, 60505-3659 — Sitagliptin and Metformin Hydrochloride, 84677-049 — Sitagliptin, 84677-050 — Sitagliptin, 84677-051 — Sitagliptin, 84677-052 — Sitagliptin and Metformin Hydrochloride, 84677-053 — Sitagliptin and Metformin Hydrochloride, +21 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels